Predicting ROR1/BCL2 Combination Targeted Therapy of Small Cell Carcinoma of the Lung

被引：0
|
作者：
Wang, W. [1 ]
Shilo, K. [1 ]
Amann, J. [1 ]
Shulman, A. [1 ]
Hojjat-Farsangi, M. [2 ]
Mellstedt, H. [2 ]
Schultz, J. [3 ]
Croce, C. [1 ]
Carbone, D. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Karolinska Inst, Stockholm, Sweden
[3] Kancera Ab, Solna, Sweden
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
SCLC; ROR1; Combinatorial Therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P47.10
引用
收藏
页码：S496 / S496
页数：1
相关论文
共 50 条
  • [41] ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
    Ghaderi, Amineh
    Daneshmanesh, Amir Hossein
    Moshfegh, Ali
    Kokhaei, Parviz
    Vagberg, Jan
    Schultz, Johan
    Olin, Thomas
    Harrysson, Sara
    Smedby, Karin E.
    Drakos, Elias
    Rassidakis, Georgios Z.
    Osterborg, Anders
    Mellstedt, Hakan
    Hojjat-Farsangi, Mohammad
    [J]. BIOMEDICINES, 2020, 8 (06)
  • [42] Tissue Expression of Activated Phosphorylated Forms of Bcl2 and Mcl1 as Prognostic Markers in Small Cell Lung Cancer
    Owonikoko, T. K.
    Chowdry, R. P.
    Chen, Z.
    Goodman, A.
    Kim, S.
    Deng, X.
    Gal, A.
    Khuri, F. R.
    Ramalingam, S. S.
    Sica, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S219 - S219
  • [43] Combination Targeted Therapy in Advanced Renal Cell Carcinoma
    Sosman, Jeffrey
    Puzanov, Igor
    [J]. CANCER, 2009, 115 (10) : 2368 - 2375
  • [44] Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion
    Henry, Claire
    Llamosas, Estelle
    Knipprath-Meszaros, Alexandra
    Schoetzau, Andreas
    Obermann, Ellen
    Fuenfschilling, Maya
    Caduff, Rosemarie
    Fink, Daniel
    Hacker, Neville
    Ward, Robyn
    Heinzelmann-Schwarz, Viola
    Ford, Caroline
    [J]. ONCOTARGET, 2015, 6 (37) : 40310 - 40326
  • [45] Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder
    Jochen Hess
    Patrick Stelmach
    Andreas Eisenhardt
    Herbert Rübben
    Henning Reis
    Kurt Werner Schmid
    Hagen Sjard Bachmann
    [J]. Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1659 - 1670
  • [46] Update on targeted therapies for small cell carcinoma of the lung
    Griffiths, Richard W.
    Lorigan, Paul
    Thatcher, Nicholas
    Blackhall, Fiona H.
    [J]. TARGETED ONCOLOGY, 2008, 3 (03) : 205 - 215
  • [47] Update on targeted therapies for small cell carcinoma of the lung
    Richard W. Griffiths
    Paul Lorigan
    Nicholas Thatcher
    Fiona H. Blackhall
    [J]. Targeted Oncology, 2008, 3
  • [48] Digital Analysis of BCL2 Expression in Laryngeal Squamous Cell Carcinoma
    Chrysovergis, Aristeidis
    Papanikolaou, Vasileios S.
    Tsiambas, Evangelos
    Ragos, Vasileios
    Peschos, Dimitrios
    Kyrodimos, Efthymios
    [J]. ANTICANCER RESEARCH, 2019, 39 (03) : 1253 - 1257
  • [49] p53 and bcl2 in lip squamous cell carcinoma
    Fontes, A.
    Trierveiler, Martins M.
    [J]. VIRCHOWS ARCHIV, 2009, 455 : 325 - 326
  • [50] Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder
    Hess, Jochen
    Stelmach, Patrick
    Eisenhardt, Andreas
    Ruebben, Herbert
    Reis, Henning
    Schmid, Kurt Werner
    Bachmann, Hagen Sjard
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (09) : 1659 - 1670
12345